The type axis of the Total Ossicular Replacement Prosthesis (TORP) market taxonomy classifies prostheses into four material‑based families, each with distinct performance and pricing profiles. Titanium TORP dominates with a 40 % share, favored for its biocompatibility, rigidity, and cost‑effectiveness, thus anchoring the bulk of volume sales. Hydroxyapatite‑based TORP, contributing 25 %, offers superior osteointegration, attracting surgeons handling complex reconstructions where long‑term stability is critical. Polymer‑based TORP, accounting for 20 %, provides flexibility and ease of customization, appealing to pediatric and revision cases that demand adaptable geometry. Bioactive‑coated TORP, the emerging segment at 15 %, integrates antimicrobial or growth‑factor layers to reduce infection risk and promote tissue regeneration, positioning it as a premium offering that commands higher unit prices. By segmenting the market along these material subtypes, analysts can trace how innovation, regulatory approval pathways, and cost structures collectively influence overall market growth.